nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.209	0.299	CbGbCtD
Letrozole—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.137	0.196	CbGbCtD
Letrozole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0445	0.0636	CbGbCtD
Letrozole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0418	0.0598	CbGbCtD
Letrozole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0418	0.0598	CbGbCtD
Letrozole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0378	0.0541	CbGbCtD
Letrozole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0378	0.0541	CbGbCtD
Letrozole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0326	0.0467	CbGbCtD
Letrozole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0317	0.0453	CbGbCtD
Letrozole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0286	0.041	CbGbCtD
Letrozole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0286	0.041	CbGbCtD
Letrozole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0275	0.0393	CbGbCtD
Letrozole—CYP19A1—semen—acquired immunodeficiency syndrome	0.00365	0.428	CbGeAlD
Letrozole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000646	0.0757	CbGeAlD
Letrozole—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000577	0.0676	CbGeAlD
Letrozole—CYP2A6—lung—acquired immunodeficiency syndrome	0.000545	0.0639	CbGeAlD
Letrozole—CYP19A1—blood—acquired immunodeficiency syndrome	0.000488	0.0572	CbGeAlD
Letrozole—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000396	0.0464	CbGeAlD
Letrozole—CYP2A6—brain—acquired immunodeficiency syndrome	0.000386	0.0453	CbGeAlD
Letrozole—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000381	0.0447	CbGeAlD
Letrozole—CYP19A1—brain—acquired immunodeficiency syndrome	0.000303	0.0355	CbGeAlD
Letrozole—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.000293	0.0343	CbGeAlD
Letrozole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000248	0.0291	CbGeAlD
Letrozole—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000238	0.000815	CcSEcCtD
Letrozole—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.000813	CcSEcCtD
Letrozole—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000238	0.000813	CcSEcCtD
Letrozole—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000237	0.000812	CcSEcCtD
Letrozole—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000237	0.000811	CcSEcCtD
Letrozole—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00081	CcSEcCtD
Letrozole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000237	0.0277	CbGeAlD
Letrozole—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.000809	CcSEcCtD
Letrozole—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.000807	CcSEcCtD
Letrozole—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000807	CcSEcCtD
Letrozole—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000235	0.000805	CcSEcCtD
Letrozole—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000235	0.000804	CcSEcCtD
Letrozole—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.000803	CcSEcCtD
Letrozole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000235	0.000803	CcSEcCtD
Letrozole—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000234	0.000802	CcSEcCtD
Letrozole—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000234	0.000801	CcSEcCtD
Letrozole—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000234	0.0008	CcSEcCtD
Letrozole—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000799	CcSEcCtD
Letrozole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.000798	CcSEcCtD
Letrozole—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000798	CcSEcCtD
Letrozole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000798	CcSEcCtD
Letrozole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000798	CcSEcCtD
Letrozole—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000232	0.000795	CcSEcCtD
Letrozole—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000795	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000792	CcSEcCtD
Letrozole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000231	0.00079	CcSEcCtD
Letrozole—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000231	0.000789	CcSEcCtD
Letrozole—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000789	CcSEcCtD
Letrozole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.000788	CcSEcCtD
Letrozole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000788	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000787	CcSEcCtD
Letrozole—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000787	CcSEcCtD
Letrozole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000786	CcSEcCtD
Letrozole—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000782	CcSEcCtD
Letrozole—Pain—Indinavir—acquired immunodeficiency syndrome	0.000229	0.000782	CcSEcCtD
Letrozole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.000782	CcSEcCtD
Letrozole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.000781	CcSEcCtD
Letrozole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.00078	CcSEcCtD
Letrozole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000779	CcSEcCtD
Letrozole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000778	CcSEcCtD
Letrozole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000778	CcSEcCtD
Letrozole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000227	0.000777	CcSEcCtD
Letrozole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000776	CcSEcCtD
Letrozole—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.000776	CcSEcCtD
Letrozole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000226	0.000774	CcSEcCtD
Letrozole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000226	0.000774	CcSEcCtD
Letrozole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000773	CcSEcCtD
Letrozole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.000771	CcSEcCtD
Letrozole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00077	CcSEcCtD
Letrozole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.000768	CcSEcCtD
Letrozole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000768	CcSEcCtD
Letrozole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000768	CcSEcCtD
Letrozole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000768	CcSEcCtD
Letrozole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000765	CcSEcCtD
Letrozole—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000765	CcSEcCtD
Letrozole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000223	0.000763	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000763	CcSEcCtD
Letrozole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.000761	CcSEcCtD
Letrozole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000759	CcSEcCtD
Letrozole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000754	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000753	CcSEcCtD
Letrozole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.000751	CcSEcCtD
Letrozole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000751	CcSEcCtD
Letrozole—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000751	CcSEcCtD
Letrozole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000219	0.000751	CcSEcCtD
Letrozole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00075	CcSEcCtD
Letrozole—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000219	0.000748	CcSEcCtD
Letrozole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000219	0.000748	CcSEcCtD
Letrozole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.000748	CcSEcCtD
Letrozole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000746	CcSEcCtD
Letrozole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000746	CcSEcCtD
Letrozole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000218	0.000745	CcSEcCtD
Letrozole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000745	CcSEcCtD
Letrozole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000743	CcSEcCtD
Letrozole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000743	CcSEcCtD
Letrozole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000739	CcSEcCtD
Letrozole—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.000739	CcSEcCtD
Letrozole—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000216	0.000739	CcSEcCtD
Letrozole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000216	0.000739	CcSEcCtD
Letrozole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000216	0.000738	CcSEcCtD
Letrozole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000737	CcSEcCtD
Letrozole—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000215	0.000737	CcSEcCtD
Letrozole—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000736	CcSEcCtD
Letrozole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000735	CcSEcCtD
Letrozole—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.000734	CcSEcCtD
Letrozole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000733	CcSEcCtD
Letrozole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000733	CcSEcCtD
Letrozole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000733	CcSEcCtD
Letrozole—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000731	CcSEcCtD
Letrozole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00073	CcSEcCtD
Letrozole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000729	CcSEcCtD
Letrozole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000728	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000727	CcSEcCtD
Letrozole—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000727	CcSEcCtD
Letrozole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000724	CcSEcCtD
Letrozole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000723	CcSEcCtD
Letrozole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000723	CcSEcCtD
Letrozole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.000722	CcSEcCtD
Letrozole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000211	0.000722	CcSEcCtD
Letrozole—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00021	0.00072	CcSEcCtD
Letrozole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000719	CcSEcCtD
Letrozole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000716	CcSEcCtD
Letrozole—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000209	0.000716	CcSEcCtD
Letrozole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000209	0.000715	CcSEcCtD
Letrozole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000715	CcSEcCtD
Letrozole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000714	CcSEcCtD
Letrozole—Rash—Stavudine—acquired immunodeficiency syndrome	0.000209	0.000714	CcSEcCtD
Letrozole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000713	CcSEcCtD
Letrozole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000713	CcSEcCtD
Letrozole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000712	CcSEcCtD
Letrozole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000712	CcSEcCtD
Letrozole—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000208	0.000711	CcSEcCtD
Letrozole—Headache—Stavudine—acquired immunodeficiency syndrome	0.000207	0.000709	CcSEcCtD
Letrozole—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000207	0.000709	CcSEcCtD
Letrozole—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000707	CcSEcCtD
Letrozole—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000207	0.000707	CcSEcCtD
Letrozole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000707	CcSEcCtD
Letrozole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000206	0.000706	CcSEcCtD
Letrozole—Rash—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000703	CcSEcCtD
Letrozole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000702	CcSEcCtD
Letrozole—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000702	CcSEcCtD
Letrozole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000702	CcSEcCtD
Letrozole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000702	CcSEcCtD
Letrozole—Headache—Abacavir—acquired immunodeficiency syndrome	0.000204	0.000698	CcSEcCtD
Letrozole—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000698	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000697	CcSEcCtD
Letrozole—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000203	0.000696	CcSEcCtD
Letrozole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000203	0.000696	CcSEcCtD
Letrozole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000692	CcSEcCtD
Letrozole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000689	CcSEcCtD
Letrozole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000687	CcSEcCtD
Letrozole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000687	CcSEcCtD
Letrozole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000683	CcSEcCtD
Letrozole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000683	CcSEcCtD
Letrozole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000682	CcSEcCtD
Letrozole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000682	CcSEcCtD
Letrozole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000682	CcSEcCtD
Letrozole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00068	CcSEcCtD
Letrozole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000679	CcSEcCtD
Letrozole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000676	CcSEcCtD
Letrozole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000197	0.000674	CcSEcCtD
Letrozole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000673	CcSEcCtD
Letrozole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000197	0.000673	CcSEcCtD
Letrozole—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000196	0.000672	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000671	CcSEcCtD
Letrozole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000669	CcSEcCtD
Letrozole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000666	CcSEcCtD
Letrozole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000665	CcSEcCtD
Letrozole—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000662	CcSEcCtD
Letrozole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000661	CcSEcCtD
Letrozole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.00066	CcSEcCtD
Letrozole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000659	CcSEcCtD
Letrozole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000192	0.0225	CbGeAlD
Letrozole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000657	CcSEcCtD
Letrozole—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000192	0.000656	CcSEcCtD
Letrozole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000656	CcSEcCtD
Letrozole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000654	CcSEcCtD
Letrozole—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000654	CcSEcCtD
Letrozole—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000654	CcSEcCtD
Letrozole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000654	CcSEcCtD
Letrozole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000654	CcSEcCtD
Letrozole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.00065	CcSEcCtD
Letrozole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000648	CcSEcCtD
Letrozole—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000647	CcSEcCtD
Letrozole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.00064	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00064	CcSEcCtD
Letrozole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000635	CcSEcCtD
Letrozole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000635	CcSEcCtD
Letrozole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000635	CcSEcCtD
Letrozole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000185	0.0217	CbGeAlD
Letrozole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000631	CcSEcCtD
Letrozole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00063	CcSEcCtD
Letrozole—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000629	CcSEcCtD
Letrozole—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000629	CcSEcCtD
Letrozole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000626	CcSEcCtD
Letrozole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000183	0.000626	CcSEcCtD
Letrozole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000183	0.000625	CcSEcCtD
Letrozole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000625	CcSEcCtD
Letrozole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000624	CcSEcCtD
Letrozole—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.00062	CcSEcCtD
Letrozole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.00062	CcSEcCtD
Letrozole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.00062	CcSEcCtD
Letrozole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000618	CcSEcCtD
Letrozole—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00018	0.000616	CcSEcCtD
Letrozole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.000612	CcSEcCtD
Letrozole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.00061	CcSEcCtD
Letrozole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000608	CcSEcCtD
Letrozole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000607	CcSEcCtD
Letrozole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000606	CcSEcCtD
Letrozole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000605	CcSEcCtD
Letrozole—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000605	CcSEcCtD
Letrozole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000605	CcSEcCtD
Letrozole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000605	CcSEcCtD
Letrozole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000602	CcSEcCtD
Letrozole—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.0006	CcSEcCtD
Letrozole—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.0006	CcSEcCtD
Letrozole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000593	CcSEcCtD
Letrozole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000591	CcSEcCtD
Letrozole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000585	CcSEcCtD
Letrozole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000585	CcSEcCtD
Letrozole—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.000584	CcSEcCtD
Letrozole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000582	CcSEcCtD
Letrozole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000582	CcSEcCtD
Letrozole—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00017	0.000582	CcSEcCtD
Letrozole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000579	CcSEcCtD
Letrozole—Rash—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000577	CcSEcCtD
Letrozole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000576	CcSEcCtD
Letrozole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000574	CcSEcCtD
Letrozole—Headache—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000573	CcSEcCtD
Letrozole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000572	CcSEcCtD
Letrozole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000566	CcSEcCtD
Letrozole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000558	CcSEcCtD
Letrozole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000555	CcSEcCtD
Letrozole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000555	CcSEcCtD
Letrozole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.00055	CcSEcCtD
Letrozole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000549	CcSEcCtD
Letrozole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000547	CcSEcCtD
Letrozole—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000545	CcSEcCtD
Letrozole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000544	CcSEcCtD
Letrozole—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000159	0.000543	CcSEcCtD
Letrozole—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000541	CcSEcCtD
Letrozole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000541	CcSEcCtD
Letrozole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.000528	CcSEcCtD
Letrozole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000526	CcSEcCtD
Letrozole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000523	CcSEcCtD
Letrozole—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000521	CcSEcCtD
Letrozole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000521	CcSEcCtD
Letrozole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000521	CcSEcCtD
Letrozole—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000518	CcSEcCtD
Letrozole—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.000513	CcSEcCtD
Letrozole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000506	CcSEcCtD
Letrozole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000504	CcSEcCtD
Letrozole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000504	CcSEcCtD
Letrozole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000497	CcSEcCtD
Letrozole—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000491	CcSEcCtD
Letrozole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000487	CcSEcCtD
Letrozole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000486	CcSEcCtD
Letrozole—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000482	CcSEcCtD
Letrozole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000482	CcSEcCtD
Letrozole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00048	CcSEcCtD
Letrozole—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000479	CcSEcCtD
Letrozole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000468	CcSEcCtD
Letrozole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000464	CcSEcCtD
Letrozole—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000464	CcSEcCtD
Letrozole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000464	CcSEcCtD
Letrozole—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000461	CcSEcCtD
Letrozole—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000454	CcSEcCtD
Letrozole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000446	CcSEcCtD
Letrozole—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000443	CcSEcCtD
Letrozole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000442	CcSEcCtD
Letrozole—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00044	CcSEcCtD
Letrozole—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000437	CcSEcCtD
Letrozole—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000417	CcSEcCtD
